Pharmaceutical

TT-01488 by TransThera Sciences (Nanjing) for Mantle Cell Lymphoma: Likelihood of Approval

TT-01488 is under clinical development by TransThera Sciences (Nanjing) and currently in Phase I for Mantle Cell Lymphoma.

May 17, 2024 - 04:00
TT-01488 is under clinical development by TransThera Sciences (Nanjing) and currently in Phase I for Mantle Cell Lymphoma.
Read the original article

Tags:

Previous Article

Influenza (quadrivalent) vaccine by Pfizer for Influenzavirus A Infections: Like...

Next Article

MRNA-1365 by Moderna for Human Metapneumovirus Infections: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Protecting your drug products: Strategies for preventing metal contamination in powders

Protecting your drug products: Strategies for preventin...

Jul 4, 2024

Dana-Farber expands studies to be retracted to 6, plus 31 to be corrected over mishandled data

Dana-Farber expands studies to be retracted to 6, plus ...

Jan 22, 2024

US court upholds Avadel’s narcolepsy drug approval amid exclusivity battle 

US court upholds Avadel’s narcolepsy drug approval amid...

Nov 3, 2024